Plain-English translation of NCT07645326 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
United States
Phase
Testing effectiveness
Sponsor
Georgetown University
Collaborators
Lantheus Medical Imaging
Enrollment target
~108 participants
Started
August 2026
Primary completion
August 2032
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Paul D Leger, MD
Georgetown University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.